HOME / ABOUT US / TXINNO PEOPLE

TXINNO PEOPLE

CEO/Co-Founder Chan Sun Park, Ph.D.

Together with Txinno Bioscience, we are intended to achieve
a grand vision of developing new innovative medicines.

CTO/Co-Founder Sungjoon Kim, Ph.D.

Based on deep scientific understanding of targets and technologies,
we aim to grow into a global company dedicated to develop new innovative medicines.

CSO / Managing director Hyouk Woo Lee, Ph.D.

By developing novel drug treatments with innovation, we are committed to provide both new hope and better life to patients.

CFO / Managing director Ki Tae Lim

By developing unprecedent and innovative new drugs, Txinno, a dedicated company developing novel drug, will take the lead to realize the dream of conquering cancer.

CDO / Managing director Jina Jung, Ph.D.

By integrating precise molecular control with optimized development strategies, we transform Txinno’s innovative pipelines into tangible therapeutic solutions for cancer patients."

CBO / Managing director Yong-yea Park, Ph.D.

Toward a better tomorrow for patients, Txinno Bioscience will always focus on improving today.

Team leader - Biology / Director Eun myong Lee, Ph.D.

To develop an innovative medicine for a healthier future, Txinno Bioscience will continue to conduct research

Team leader - Preclinacal / Director Eun-young Kwak

Our dream is to make life of patients to be with full of hope by developing novel and innovative medicine at Txinno Bioscience.

Team leader - Pharmacology / Director Hong jun Kang

With innovative medicine, TXINNO Bioscience is turning the page to transform patients' lives.

Team leader - medicinal chemistry III / Director Do hoon Lee

Creating tomorrow’s health through today’s research.

    Research Division

  • Chemistry teamPassionate and never give up

    We are dedicated to develop innovative new medicines that can heal body and mind of patients and their families.

  • Biology teamMake tomorrow better by us

    We are developing new medicine with warm-hearted devotion for patients and their families.

  • ADME teamBig idea with warm heart

    We are developing innovative new medicines with an open mind, visualizing a hopeful future for patients and their families.

  • Pharmacology teamWith mind of loving and caring all life

    We are developing innovative anti-cancer drug that are safe and beneficial to all cancer patients.

    Development Division

  • Preclinical teamDetermined to develop safe cancer medicines

    We are developing novel medicines restoring a normal life of cancer patients and their family.

  • Clinical teamFor the benefit of cancer patients

    We are intended to conduct clinical trials that reduce the side effects of anticancer drugs and maximize their efficacy.

    Management Planning Division

  • Financial Planning teamA challenge towards global biotech

    We are preparing and planning for the future to propel Txinno into a global company.

  • HR/GA teamFor a better day than last one

    We are building a horizontal company culture in which everyone is happy and fulfilling based on mutual trust and open communication.

    Business Strategy Division

  • Business Development teamFor successful drug
    development “Business”

    We are committed to enhancing corporate value by developing market-competitive anti-cancer treatments.